MAP3K5 and renal fibrosis: However, this is a reasonable conclusion to draw given the exquisite selectivity of GS‐444217 for targeting ASK1 and that studies in the unilateral ureteric obstruction model of renal fibrosis gave remarkably similar results using Ask1 gene deletion and GS‐444217 treatment (23 and unpublished data).